Quidel

Quidel

Develops and markets diagnostic testing solutions

About

Quidel Corporation develops and manufactures diagnostic testing solutions for healthcare professionals. Their products include a variety of tests used to detect diseases, focusing on areas like infectious diseases, reproductive health, bone health, and virology. Quidel's tests, such as lateral flow tests and molecular diagnostics, are designed to be used in hospitals, clinics, and laboratories. The company stands out from competitors by investing significantly in research and development to create new tests and improve existing ones, as well as expanding through strategic acquisitions. A notable achievement is their rapid antigen test for COVID-19, which is faster and simpler than traditional methods. Quidel's goal is to provide reliable diagnostic solutions that enhance healthcare outcomes globally.

Company Stage

Grant

Employees

501-1,000

Industries

Healthcare

Total Funding

$617.3K

Headquarters

N/A

Founded

1937


Simplify Jobs

Simplify's Take

What believers are saying

  • Quidel's commitment to R&D ensures continuous innovation and improvement of diagnostic tests, providing employees with opportunities to work on cutting-edge technologies.
  • The company's strong market position and diverse product portfolio offer stability and growth potential for employees.
  • Strategic partnerships and acquisitions, like the one with Global Lyme Alliance, enhance Quidel's reputation and open new avenues for professional development.

What critics are saying

  • The class action lawsuit alleging securities fraud could lead to financial and reputational damage, affecting employee morale and job security.
  • The highly competitive diagnostics market requires constant innovation, which can be resource-intensive and challenging to sustain.

What makes Quidel unique

  • Quidel's rapid antigen test for COVID-19, which received FDA emergency use authorization, sets it apart as a leader in pandemic response diagnostics.
  • The company's extensive portfolio, including lateral flow tests, DFA tests, and molecular diagnostics, offers a comprehensive range of solutions that few competitors can match.
  • Quidel's strategic acquisitions, such as Mesa Biotech and Ortho Clinical Diagnostics, have significantly expanded its market presence and product offerings.

Help us improve and share your feedback! Did you find this helpful?


Benefits

Medical, dental, & vision

401k

Income replacement

Employee stock purchase plan

Vacation & Holidays

Great work environment

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Quidel right now.

Find jobs on Simplify and start your career today

💡
We update Quidel's jobs every 8 hours, so check again soon! Browse all jobs →